Revenue Growth
Total Q1 revenue $210.0M, up 5% year-over-year and toward the high end of guidance.
Industrial Segment Outperformance
Industrial revenues $65.0M (31% of sales), up 17% year-over-year driven by cargo systems shipments and repeat orders; management calls Industrial an attractive growth opportunity.
Medical Segment Stability and CT Strength
Medical revenues $145.0M (69% of sales), broadly stable year-over-year with particular strength in high-end CT and growing design engagement around next-generation platforms.
Profitability (Non-GAAP)
Non-GAAP gross margin 34% (high end of guidance); non-GAAP EBITDA $29M, up 12% year-over-year; non-GAAP EPS $0.19 vs $0.10 prior year (up $0.09, ~90% increase).
Strong Customer Engagement and Pipeline (RSNA)
150+ customer meetings at RSNA, positive reception to modality-based integrated subsystems (tubes, detectors, software), increased design-win pipeline with potential revenue conversion in FY27+.
Progress on India Manufacturing Strategy
Detector factory in India is producing and shipping globally; tube factory construction largely complete with equipment installation and qualification underway (tube shipments from India expected after ~12 months); management views this as strategic for market access.
Regional Strength — Americas and EMEA
Americas revenue growth +17% YoY (driven by Industrial/cargo); EMEA up 7% YoY, indicating geographic demand pockets outside APAC.
Order Activity and Product Momentum in Industrial Verticals
Multiple cargo system installations and orders in the quarter, plus solid demand for photon counting detectors in industrial/food inspection and strength in nondestructive testing (linear accelerators, X-ray tubes).